MCU Inhibitor Ruthenium Red Alleviates the Osteoclastogenesis and Ovariectomized Osteoporosis via Suppressing RANKL‐Induced ROS Production and NFATc1 Activation through P38 MAPK Signaling PathwayYuxin Wang, Fengchao Zhao|Oxidative Medicine and Cellular Longevity|2022Cited by 11
Tetrandrine inhibits RANKL-induced osteoclastogenesis by promoting the degradation of TRAILJiarui Li, Fengchao Zhao|Molecular Medicine|2022Cited by 11
StemRegenin 1 attenuates the RANKL-induced osteoclastogenesis via inhibiting AhR-c-src-NF-κB/p-ERK MAPK-NFATc1 signaling pathwayShengji Zhou, Fengchao Zhao|iScience|2024Cited by 10